Alabama Litigation Review

Alabama Litigation Review

Insights & Commentary on Developments in Alabama Litigation

Tag Archives: mass tort

The Government Has A Record Year Seeking Justice For Wrongful Conduct by the Drug Industry

Posted in Defective Products
Yesterday, the United States Department of Justice announced that it had recovered $3 Billion in fiscal year 2010 against those companies and individuals who had defrauded our government.  These recoveries involved claims for all types of fraud against our government, including military contracts, non-military contracts, federally-insured mortgages, and mineral leases, among others.  It is a welcome… Continue Reading

Depuy Hip Replacement Implants and the Influence of Medical Device Manufacturers over Physicians

Posted in Defective Products
Last month I discussed the recent recall of the ASR hip replacement products manufactured by Depuy Orthopedics.  With over 90,000 of these medical implants sold, this is a tremendous issue that will affect many people.  These defective implants can result in significant injuries and damages to the individuals using them.  How will Depuy treat the patients who underwent these… Continue Reading

Was the FDA Advisory Panel on Avandia Tainted by Conflict?

Posted in Defective Products
It’s been an eventful summer for GlaxoSmithKline (GSK) and its diabetes drug, Avandia.  First, the New York Times dropped its bombshell that secret company testing in 1999 indicated the increased risk of heart attacks associated with Avandia.  Yet, the company may have hidden its own test results, while reaping billions of dollars in revenue continuing… Continue Reading

Did Diabetes Drug Maker Hide Its Own Test Results Which Revealed Health Risks?

Posted in Defective Products
Explosive!  That’s the bombshell dropped by The New York Times yesterday.  The article involves the drug Avandia, manufactured by GlaxoSmithKline (introduced to the market by its predecessor SmithKline Beecham).  Avandia entered the market in 1999 as a drug to treat diabetes.  Since then, GlaxoSmithKline has reaped enormous revenue from the sale of this drug.  To… Continue Reading

Congress Holds Hearings On The “Foreign Manufacturers Legal Accountability Act”

Posted in Defective Products
Previously, I wrote about legislation introduced into the U.S. House of Representatives to protect American consumers from dangerous and defective imported products.  The statistics are very troubling.  In 2009, 83% of the recalls announced by The Consumer Product Safety Commission (CPSC) were from foreign manufacturers.  Statistics from recent prior years are similar. Last week, a… Continue Reading

Foreign Manufacturers Account For Most Product Recalls

Posted in Defective Products
A study by The American Association for Justice shows that eighty-three percent (83%) of the recalls announced by The Consumer Product Safety Commission (CPSC) in 2009 were from foreign manufacturers.  The results for 2008 were similar.  What happens when one of these defective foreign-made products injures someone? The recent litigation concerning defective Chinese drywall highlights… Continue Reading